# Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence

> **NCT01847469** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 24 (actual)

## Conditions studied

- Alcohol Dependence
- Post-Traumatic Stress Disorder (PTSD)

## Interventions

- **BEHAVIORAL:** Enhanced-Cognitive Processing Therapy-C (E-CPT-C)
- **DRUG:** Zonisamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01847469
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847469, "Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01847469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*